Amiodarone Decreases Heat, Cold, and Mechanical Hyperalgesia in a Rat Model of Neuropathic Pain

Anesthesia and Analgesia

Volumn 98, Issue 1, 2004, Pages 178-184

  Datta, Sukdeb ^a,b   Waghray, Taruna ^a   Torres, Maria ^a   Glusman, Silvio ^a  

^a Jr Hospital of Cook County   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONE; AMIODARONE; LIDOCAINE; SODIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLD; COLD SENSITIVITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG HALF LIFE; HEART VENTRICLE FUNCTION; HEAT; HYPERALGESIA; MALE; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; RAT; SCIATIC NERVE; STIMULUS RESPONSE; TEMPERATURE DEPENDENCE;

EID: 0347993862     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000093223.35824.23     Document Type: Article

References (28)

1. Bach FW, Jensen TS, Kastrup J. The effects of intravenous lidocaine on nociceptive processing in diabetic neuropathy. Pain 1990;40:29-34.
2. Boas RA, Shahnarian A. Analgesic response to intravenous lidocaine. Br J Anaesth 1982;54:501-5.
3. Kastrup J, Peterson P, Dejgard A, et al. Intravenous lidocaine infusion: a new treatment for chronic painful diabetic neuropathy? Pain 1987;28:69-75.
4. Marchettini P, Lacerenza M, Marangoni C, et al. Lidocaine test in neuralgia. Pain 1992;48:377-82.
5. Abram SE, Yaksh TL. Systemic lidocaine blocks nerve injury-induced hyperalgesia and nociceptor-driven spinal sensitization in the rat. Anesthesiology 1994;80:383-91.
6. + channels: local anesthetics, antiarrhythmics and anticonvulsants. Trends Pharmacol Sci 1987;8:57-65.
7. Woolf CJ, Wiesenfeld-Hallin Z. The systemic administration of local anesthetics produces a selective depression of C-afferent fibre evoked activity in the spinal cord. Pain 1985;23:361-74.
8. Garfield JM, Gugino L. Central effects of local anesthetic agents. In: Strichartz GR, ed. Local anesthetics. Berlin: Springer-Verlag, 1987:253-84.
9. Pollack PT. Oral amiodarone: historical overview and development. Pharmacotherapy 1998;18:121S-6.
10. Naccarelli GV, Jalal S. Intravenous amiodarone: another option in the acute management of sustained ventricular tachyarrhythmias. Circulation 1995;92:3154-5.
11. Kodama I, Kamiya K, Toyama J. Amiodarone: Ionic and cellular mechanisms of action of the most promising class III agent. Am J Cardiol 1999;84:20R-8.
12. Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988;33:87-107.
13. Hargreaves K, Dubner R, Brown F, et al. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988;32:77-88.
14. Choi Y, Yoon YW, Na HS, et al. Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain. Pain 1994;59:369-76.
15. Ren K, Dubner R. NMDA receptor antagonists attenuate mechanical hyperalgesia in rat with unilateral inflammation of the hindpaw. Neurosci Lett 1993;63:22-6.
16. Kontinen VK, Aarnisalo AA, Idanpaan-Jeikkila JJ, et al. Neuropeptide FF in the rat spinal cord during carrageenan inflammation. Peptides 1997;18:287-92.
17. Wagner JA, Weisman HF, Levine JH, et al. Differential effect of amiodarone and desethylamiodarone on calcium antagonist receptors. J Cardiovasc Pharmacol 1990;15:501-7.
18. Du XJ, Esler MD, Dart AM. Sympatholytic action of intravenous amiodarone in the rat heart. Circulation 1995;91:462-70.
19. Haikerwal D, Du XJ, Turner A, et al. Presynaptic antisympathetic action of amiodarone and its metabolite desethylamiodarone. J Cardiovasc Pharmacol 1999;33:309-15.
20. Matsumori A, Ono K, Nishio R, et al. Amiodarone inhibits production of tumor necrosis factor-a by human mononuclear cells: a possible mechanism for its effect in heart failure. Circulation 1997;96:1386-9.
21. Ito H, Ono K, Nishio R, et al. Amiodarone inhibits interleukin 6 production and attenuates myocardial injury induced by viral myocarditis in mice. Cytokine 2002;17:197-202.
22. Plomp TA, Wiersinga WM, Maes RA. Tissue distribution of Amiodarone and desethylamiodarone in rats after multiple intraperitoneal administrations of various amiodarone doses. Arzneimittelforschung 1985;35:122-9.
23. Plomp TA, Wiersinga WM, Van Rossum JM, Maes RA. Pharmacokinetics and body distribution of amiodarone and desmethylamiodarone in rats after oral administration. In Vivo 1987;1:265-79.
24. Abdi S, Lee DH, Chung JM. The anti-allodynic effects of amitriptyline, gabapentin and lidocaine in a rat model of neuropathic pain. Anesth Analg 1998;87:1360-6.
25. Riva E, Gerna M, Neyroz P, et al. Pharmacokinetics of amiodarone in rats. J Cardiovasc Pharmacol 1982;4:270-5.
26. Weir SJ, Ueda CT. Amiodarone pharmacokinetics. I. Acute dose-dependant disposition studies in rats. J Pharmacokinet Biopharm 1986;14:601-13.
27. Kannan R, Sharma JS, Guha M, Venkataraman K. Tissue drug accumulation and ultrastructural changes during amiodarone administration in rats. Fundam Appl Toxicol 1989;13:793-803.
28. Latini R, Bizzi A, Cini M, et al. Amiodarone and desethylamiodarone tissue uptake in rats chronically treated with amiodarone is non-linear with the dose. J Pharm Pharmacol 1987;39:426-31.